To explore the underlying molecular mechanisms of supraventricular tachycardia (SVT), this study aimed to analyse the complex relationship between FLRT3 and TGF‐β/SMAD4 signalling pathway, which affects Na+ and K+ channels in cardiomyocytes. Bioinformatics analysis was performed on 85 SVT samples and 15 healthy controls to screen overlapping genes from the key module and differentially expressed genes (DEGs). Expression profiling of overlapping genes, coupled with Receiver Operating Characteristic (ROC) curve analyses, identified FLRT3 as a hub gene. In vitro studies utilizing Ang II‐stimulated H9C2 cardiomyocytes were undertaken to elucidate the consequences of FLRT3 silencing on cardiomyocyte apoptosis and autophagic processes. Utilizing a combination of techniques such as quantitative reverse‐transcription polymerase chain reaction (qRT‐PCR), western blotting (WB), flow cytometry, dual‐luciferase reporter assays and chromatin immunoprecipitation polymerase chain reaction (ChIP‐PCR) assays were conducted to decipher the intricate interactions between FLRT3, the TGF‐β/SMAD4 signalling cascade and ion channel gene expression. Six genes (AADAC, DSC3, FLRT3, SYT4, PRR9 and SERTM1) demonstrated reduced expression in SVT samples, each possessing significant clinical diagnostic potential. In H9C2 cardiomyocytes, FLRT3 silencing mitigated Ang II‐induced apoptosis and modulated autophagy. With increasing TGF‐β concentration, there was a dose‐responsive decline in FLRT3 and SCN5A expression, while both KCNIP2 and KCND2 expressions were augmented. Moreover, a direct interaction between FLRT3 and SMAD4 was observed, and inhibition of SMAD4 expression resulted in increased FLRT3 expression. Our results demonstrated that the TGF‐β/SMAD4 signalling pathway plays a critical role by regulating FLRT3 expression, with potential implications for ion channel function in SVT.
16 August 2022 in Journal of Interventional Cardiac Electrophysiology
Background: To compare the safety, effectiveness, electrophysiological characteristics, and mechanisms of different approaches for the ablation of para-Hisian accessory pathways (APs). Method: Eighteen consecutive patients with para-Hisian APs were enrolled in this study. Detailed mapping of retrograde conduction as well as antegrade conduction (if possible) in both the right sided His bundle region and non-coronary cusp (NCC) region was performed before ablation. Ten patients underwent initial ablation in the right septal (RS) region while the remaining 8 patients were ablated in NCC region. Repeat ablation was attempted in an alternative region if ablation at the first site failed. Results: Among the patients whose procedures were successful, 7 cases were successfully ablated with a NCC approach while 10 were conventionally ablated in RS region. For successful procedures targeting the NCC region, the earliest atrial activation (EAA) in NCC region preceded that at RS region by 4–13 ms. The distance between NCC targets and near-field His potential (NFH) points was longer than that between RS targets and NFH points. Additionally, the risk of complication after ablation in NCC region was lower compared with that following RS-targeted procedure. Conclusion: NCC approach provided a high success rate and low risk of complication for the ablation of para-Hisian APs as long as EAA was observed in NCC region. Sites of successful para-Hisian AP ablation in NCC region had different retrograde mapping patterns in comparison with successful ablation sites in the RS region.
28 April 2022 in Journal of Interventional Cardiac Electrophysiology
A total of 172 consecutive patients with sympathetic paroxysmal atrial fibrillation who received cryoballoon (CB) ablation from 2020 to 2021 were retrospectively analyzed in this study. Catheter coaxiality and anatomic features of pulmonary veins (PVs) on computed tomography images were explored by several parameters and their influence on the cryoablation results was then analyzed. The rate of incomplete CB occlusion was significantly higher for inferior than superior PVs. A multivariate analysis revealed that a short distance (<6.3 mm) from PV ostium to first branch (D-PVB) and a small angle (<32.5°) of first branch were independent predict factors for an incomplete CB occlusion in right inferior PVs (RIPVs). A combination of D-PVB and angle of first branch could elevate the predictor value for an incomplete balloon occlusion with a sensitivity of 0.85 and specificity of 1.0 for RIPVs. For PVs with a perfect balloon occlusion, the best catheter coaxiality was observed in right superior PV while the worst catheter coaxiality was observed in RIPV. A more aggressive catheter manipulation with a "7" or "reverse-U" shape of long sheath could obtain a better catheter coaxiality compared with conventional manipulation strategy for RIPVs. In Conclusion, a short D-PVB and a small angle of first branch were independent predict factors for an incomplete CB occlusion in RIPVs. A more aggressive catheter manipulation strategy was recommended to achieve a complete balloon occlusion and a better catheter coaxiality for RIPVs.
Background: Intracardiac echocardiography (ICE)-guided percutaneous endocardial septal ablation (PESA) is a promising alternative strategy for symptomatic hypertrophic obstructive cardiomyopathy (HOCM). However, the extent of left ventricular outflow tract gradient (LVOTG) reduction after PESA varies considerably among patients, and reliable echocardiographic predictors of procedural efficacy remain unclear. We aimed to identify echocardiographic predictors of procedural efficacy and to describe our ablation strategy. Methods: We retrospectively analyzed 30 consecutive symptomatic HOCM patients who underwent ICE-guided PESA. The primary endpoint was the absolute change in resting LVOTG from baseline to the 1-year follow-up; a key secondary endpoint was significant gradient reduction, defined as a ≥50% decrease in resting LVOTG. Associations between LVOTG reduction and baseline echocardiographic parameters, particularly anterior mitral leaflet length (AMLL) and interventricular septal thickness (IVST), were evaluated. Results: At 1 year, the mean resting LVOTG decreased from 86.03 ± 24.30 mmHg to 41.43 ± 18.49 mmHg (p < 0.001). For the key secondary endpoint (≥50% resting LVOTG reduction), AMLL was the only variable associated with the outcome in the prespecified multivariable logistic model (OR per 1 mm increase: 0.429; p = 0.006), with consistent findings in a Firth penalized logistic regression sensitivity analysis. ROC analysis identified an exploratory AMLL cutoff of approximately 29 mm (AUC 0.920; sensitivity 90%; specificity 80%). In the continuous-outcome analysis, each 1 mm increase in AMLL corresponded to approximately 4.3 mmHg less LVOTG reduction (β = −4.32; p < 0.001). Thinner IVST was not significantly associated with greater procedural efficacy (p = 0.052), suggesting a potential thickness-dependent limit that warrants further investigation. Conclusions: ICE-guided PESA effectively reduces LVOT obstruction in HOCM. Shorter AMLL predicted greater LVOT gradient reduction in this exploratory cohort, and a Youden-derived AMLL cutoff of approximately 29 mm may help identify patients who are more likely to achieve substantial gradient reduction.